A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections.
Wang
Jin
J
Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China.
Xiao
Yonghong
Y
Huang
Wenxiang
W
Xu
Nan
N
Bai
Chunxue
C
Xiu
Qingyu
Q
Mei
Changlin
C
Zheng
Qingshan
Q